Genomics Lab

Access leading-edge technologies, scientific experts and Genomics Know-How®. Q2 Solutions | EA Genomics, advances science from understanding the human genome and disease biology to detecting the effects of therapies. 

Tailored genomic solutions

We offer a range of genomic services to support drug discovery, precision medicine and clinical development. Our industry-leading genomic services team can help you uncover invaluable insights from your data. Our experts design smarter studies to help you:

           Genomic services to help develop safer and more effective medicines 

We provide whole genome to focused set gene expression profiling and genotyping assays along with DNA and RNA sequencing services, sequence enrichment technologies and bioinformatics analysis expertise to support all product development needs. We offer tailored solutions for challenging specimens such as whole blood and FFPE tissues, as well as nucleic acid isolation and data analysis services.

Delivery excellence

Through carefully orchestrated analyses, we work with you to choose platforms and assays that will distinctly fit your needs, and then use them to deliver valuable, informative data. Our solutions support our clients’ clinical trial and research efforts across the industry spectrum. We work with pharmaceutical, biotechnology, medical device/diagnostic, academic, government and nonprofit clients using a wide array of technology platforms, so that we can determine exactly what works best for you without sacrificing quality or efficiency.   

Our quality system follows CLSI guidelines and our CLIA-certified and CAP Accredited laboratory supports GLP compliance.

Shaping outcomes 

Accelerate drug development with genomic know-how®. Partner with our experts to determine the best methods to obtain the data you need to solve complex biological problems, realize efficiencies, mitigate risks and improve your clinical outcomes. 

submit specimens for genomic services
client login for genomic services
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 11 Immune Landscape Signatures

T-cell Receptor (TCR) Sequencing Assay for Characterization of Adaptive Immune Response

Detects TCRβ and TCRγ clonotypes expressed at the mRNA level

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

Q2 Solutions Genomic Laboratory Services

Genomic Know-How® for your drug development needs

The importance of bioinformatics in immuno-oncology development

Big data solutions and bioinformatics services for genomic insights

Genomic Assays for Clinical Development

Identifying the right approach from a wealth of potential options

Genomic Based Solutions for Your Immuno-oncology Drug Development Needs

Genomics-based biomarker approach

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Leveraging Genomics-Based Assays for Immuno-Oncology in Clinical Research

Molecular Medicine Tri-Conference 2017

Q2 Solutions Comprehensive Cancer Panel

Targeted sequencing assay

Precision Medicine – Leveraging Genomics in Clinical Research

Part one

Precision Medicine: Applying Genomics Outside of Oncology

Part two

Genomics throughout the Drug Development Process

Part three

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Translating Data into Insights with Bioinformatics

Read More